Fibroblast activation protein ligands for targeted delivery applications

The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAKHEL PLAZA, Sheila, CAZZAMALLI, Samuele, MILLUL, Jacopo, SAMAIN, Florent, BIANCOFIORE, Ilaria, SCHMIDT, Eleonore, DONCKELE, Etienne J
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DAKHEL PLAZA, Sheila
CAZZAMALLI, Samuele
MILLUL, Jacopo
SAMAIN, Florent
BIANCOFIORE, Ilaria
SCHMIDT, Eleonore
DONCKELE, Etienne J
description The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2021220663A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2021220663A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2021220663A13</originalsourceid><addsrcrecordid>eNqNy0EKwjAQQNFsXIh6hwHXQptC90UsPYCuyzSZloEhCZmh4O0F8QCu_ub9o5tGXmpeBNUAg_GOxjlBqdmIEwhvmKLCmisY1o2MIkQS3qm-AUsRDt9Dz-6woihdfj256_h43qcblTyTFgyUyObh5Rvfet_0fTe03X_qA93ZNe4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fibroblast activation protein ligands for targeted delivery applications</title><source>esp@cenet</source><creator>DAKHEL PLAZA, Sheila ; CAZZAMALLI, Samuele ; MILLUL, Jacopo ; SAMAIN, Florent ; BIANCOFIORE, Ilaria ; SCHMIDT, Eleonore ; DONCKELE, Etienne J</creator><creatorcontrib>DAKHEL PLAZA, Sheila ; CAZZAMALLI, Samuele ; MILLUL, Jacopo ; SAMAIN, Florent ; BIANCOFIORE, Ilaria ; SCHMIDT, Eleonore ; DONCKELE, Etienne J</creatorcontrib><description>The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221006&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021220663A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221006&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021220663A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAKHEL PLAZA, Sheila</creatorcontrib><creatorcontrib>CAZZAMALLI, Samuele</creatorcontrib><creatorcontrib>MILLUL, Jacopo</creatorcontrib><creatorcontrib>SAMAIN, Florent</creatorcontrib><creatorcontrib>BIANCOFIORE, Ilaria</creatorcontrib><creatorcontrib>SCHMIDT, Eleonore</creatorcontrib><creatorcontrib>DONCKELE, Etienne J</creatorcontrib><title>Fibroblast activation protein ligands for targeted delivery applications</title><description>The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy0EKwjAQQNFsXIh6hwHXQptC90UsPYCuyzSZloEhCZmh4O0F8QCu_ub9o5tGXmpeBNUAg_GOxjlBqdmIEwhvmKLCmisY1o2MIkQS3qm-AUsRDt9Dz-6woihdfj256_h43qcblTyTFgyUyObh5Rvfet_0fTe03X_qA93ZNe4</recordid><startdate>20221006</startdate><enddate>20221006</enddate><creator>DAKHEL PLAZA, Sheila</creator><creator>CAZZAMALLI, Samuele</creator><creator>MILLUL, Jacopo</creator><creator>SAMAIN, Florent</creator><creator>BIANCOFIORE, Ilaria</creator><creator>SCHMIDT, Eleonore</creator><creator>DONCKELE, Etienne J</creator><scope>EVB</scope></search><sort><creationdate>20221006</creationdate><title>Fibroblast activation protein ligands for targeted delivery applications</title><author>DAKHEL PLAZA, Sheila ; CAZZAMALLI, Samuele ; MILLUL, Jacopo ; SAMAIN, Florent ; BIANCOFIORE, Ilaria ; SCHMIDT, Eleonore ; DONCKELE, Etienne J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2021220663A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DAKHEL PLAZA, Sheila</creatorcontrib><creatorcontrib>CAZZAMALLI, Samuele</creatorcontrib><creatorcontrib>MILLUL, Jacopo</creatorcontrib><creatorcontrib>SAMAIN, Florent</creatorcontrib><creatorcontrib>BIANCOFIORE, Ilaria</creatorcontrib><creatorcontrib>SCHMIDT, Eleonore</creatorcontrib><creatorcontrib>DONCKELE, Etienne J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAKHEL PLAZA, Sheila</au><au>CAZZAMALLI, Samuele</au><au>MILLUL, Jacopo</au><au>SAMAIN, Florent</au><au>BIANCOFIORE, Ilaria</au><au>SCHMIDT, Eleonore</au><au>DONCKELE, Etienne J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fibroblast activation protein ligands for targeted delivery applications</title><date>2022-10-06</date><risdate>2022</risdate><abstract>The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2021220663A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Fibroblast activation protein ligands for targeted delivery applications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T22%3A41%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAKHEL%20PLAZA,%20Sheila&rft.date=2022-10-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2021220663A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true